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Thrombospondin type I repeat (TSR) domains are commonly O-fucosylated by protein
O-fucosyltransferase 2 (PoFUT2), and this modification is required for optimal folding
and secretion of TSR-containing proteins. The human malaria parasite Plasmodium
falciparum expresses proteins containing TSR domains, such as the thrombospondin-
related anonymous protein (TRAP) and circumsporozoite surface protein (CSP), which
are O-fucosylated. TRAP and CSP are present on the surface of sporozoites and play
essential roles in mosquito and human host invasion processes during the transmission
stages. Here, we have generated PoFUT2 null-mutant P. falciparum and Plasmodium
berghei (rodent) malaria parasites and, by phenotyping them throughout their complete
life cycle, we show that PoFUT2 disruption does not affect the growth through the
mosquito stages for both species. However, contrary to what has been described
previously by others, P. berghei PoFUT2 null mutant sporozoites showed no deleterious
motility phenotypes and successfully established blood stage infection in mice. This
unexpected result indicates that the importance of O-fucosylation of TSR domains may
differ between human and RODENT malaria parasites; complicating our understanding
of glycosylation modifications in malaria biology.
Keywords: Plasmodium falciparum, Plasmodium berghei, O-fucosylation, protein O-fucosyltransferase 2, oocyst,
sporozoite
INTRODUCTION
Malaria is one of the most important human parasitic diseases, causing ∼219 million new cases
and more than 400,000 deaths every year (WHO, 2018). It is caused by a protozoan apicomplexan
parasite of the genus Plasmodium, with Plasmodium falciparum regarded as the deadliest species.
Plasmodium parasites are transmitted by female Anophelesmosquitoes. After the bite of an infected
mosquito, motile sporozoites are injected into the human dermis; from there, they travel through
blood vessels to the liver and infect hepatocytes. A week later, the infected hepatocyte ruptures
and releases merozoites that reach the blood circulation and invade erythrocytes initiating cyclical
asexual reproduction. A small percentage of blood stage parasites become sexually committed cells
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known as gametocytes, which are taken up during a mosquito
blood meal. Once in the mosquito midgut, gametocytes develop
into gametes, fertilization takes place, and zygotes are formed.
These zygotes develop into motile ookinetes that traverse
the mosquito midgut wall to form oocysts. Each oocyst can
develop into thousands of sporozoites that invade the mosquito
salivary glands and are ready to infect another human host
(Menard et al., 2013).
Thrombospondin type 1 repeat (TSR) domains are small
(50–60 amino acid residues) cysteine-knot motifs with 3
conserved disulfide bonds that play important roles in cell
adhesion andmotility (Adams and Tucker, 2000; Tan et al., 2002).
Plasmodium parasites express several TSR domain-containing
proteins throughout the different stages of their life cycle that are
critical for host cell recognition, motility, and invasion (Morahan
et al., 2009). These proteins include circumsporozoite protein
(CSP) and thrombospondin-related anonymous protein (TRAP)
in the sporozoite stage and circumsporozoite and TRAP-related
protein (CTRP) in the ookinete stage (Wengelnik et al., 1999;
Coppi et al., 2011; Mathias et al., 2013). Antibodies against these
proteins inhibit host cell invasion and block the progression of
the parasite’s life cycle (Chattopadhyay et al., 2003; Li et al.,
2004). Hence, TSR domain-containing proteins are potentially
important vaccine targets (Moorthy et al., 2004). Indeed, the
licensed malaria vaccine RTS,S (Mosquirix) is based on CSP
(RTS,S Clinical Trials Partnership, 2015).
TSR domains are O-fucosylated by protein
O-fucosyltransferase 2 (PoFUT2) (Luo et al., 2006; Leonhard-
Melief and Haltiwanger, 2010). That fucose can be further
elongated with a glucose residue, generating an O-linked
disaccharide (Kozma et al., 2006). This modification is important
for the secretion of TSR domain-containing proteins (Ricketts
et al., 2007; Wang et al., 2007; Vasudevan and Haltiwanger,
2014). A recent report demonstrated that CSP and TRAP TSR
domains are also O-fucosylated in the Plasmodium sporozoite
stage (Swearingen et al., 2016). A homolog of PoFUT2 is
conserved in all the Plasmodium species sequenced (Cova
et al., 2015), and the parasite synthesizes the GDP-fucose
(GDP-Fuc) precursor required for O-fucosylation (Sanz et al.,
2013, 2016; López-Gutiérrez et al., 2017). In a recent study,
Lopaticki et al. (2017) characterized the P. falciparum protein
O-fucosyltransferase (PoFUT2) and showed that it is involved
in the O-fucosylation of parasite TSR domains. The authors
reported that PoFUT2 genetic disruption in P. falciparum
resulted in a reduction in the ability of ookinetes to traverse the
mosquito midgut to form oocysts. They also provided evidence
showing that mosquitoes infected with 1PoFUT2 parasites
harbored significantly fewer sporozoites in the mosquito salivary
glands compared to mosquitoes infected with the wild type
P. falciparum parental line, NF54. Finally, they assessed the
infectivity of salivary gland sporozoites by analyzing their
motility, cell traversal activity, and hepatocyte invasion and
by carrying out co-infection experiments using wild type and
mutant parasites in a humanized chimeric liver mouse model;
these assays revealed an apparent lower fitness of 1PoFUT2
parasites in completing development in the mosquito and
infecting mammalian hepatocytes compared to wild type NF54.
Here, we report a robust study that differs from the central
results of the previous report and reveals that under laboratory
conditions, that PoFUT2 is not essential for murine parasite
development and transmission.
MATERIALS AND METHODS
Ethics Statement
The human blood used for mosquito blood meals and P.
falciparum culture was collected from a pool of pre-screened
donors under an IRB-approved protocol at Johns Hopkins
University (Protocol NA00019050) or obtained commercially
from anonymous donors through Interstate Blood Bank or
Banc de Sang i Teixits (Catalonia, Spain), after approval
from the Comitè Ètic Investigació Clínica Hospital Clínic
de Barcelona, making informed consent not applicable.
Animal experiments were approved by the Portuguese official
veterinary department for welfare licensing and the Instituto
de Medicina Molecular Animal Ethics Committee. All animal
experiments were performed in strict compliance to the
guidelines of the institution’s animal ethics committee and
the Federation of European Laboratory Animal Science
Associations (FELASA).
P. falciparum Asexual Parasite Culture and
Transfection
P. falciparum NF54 parasites (PfWT) (a kind gift of Teun
Bousema, Radboud University Nijmegen Medical Center) were
cultured with human B+ erythrocytes (2–4% hematocrit) in
complete culture medium (RPMI media [Sigma] supplemented
with 10% AB+ human serum or 0.5% Albumax II), incubated
at 37◦C in an atmosphere of 92% N2, 3% O2, and 5% CO2
using standard methods (Trager and Jensen, 1976). PfWT
parasites were transfected by schizont nucleofection as described
previously (Moon et al., 2013). After the appearance of resistant
parasites, on/off drug cycling with WR22910 using 2-week cycles
was used, followed by negative selection with 5-fluorocytosine
(5FCyt) to select double recombinant parasites. Integrant clonal
parasites were obtained by limiting dilution.
P. falciparum Transfection Construct
pCC1-PfPoFUT2 transfection construct (Maier et al., 2006)
consisted of two fragments of ≈ 850 and ≈ 960 bp, respectively,
from different regions of the PfPoFUT2 locus. F1 (nucleotides
from−361 to+479 of the PfPoFUT2 locus) and F2 (nucleotides
from +1363 to 630 after the PfPoFUT2 locus) fragments were
amplified with primers pf3 (CAATGGCCCCTTTCCGCGGTCT
TATGTCTTATTCTCATTTTGCTT) and pf4 (AGATCTTCGG
ACTAGTCTTTTTGTAGCTGCAAGGGGG) for fragment F1,
and pf5 (ATCGATAACTCCATGGTGAGCAATGGATTTGT
ACAAGGT) and pf6 (CAGGCGCCAGCCTAGGTCAAGTGC
AAGGGTTCTTTT) for fragment F2. The construct generated
would integrate into the PoFUT2 locus, disrupting it by double
crossover homologous recombination (Figure 1A).
P. falciparum Southern Blotting and
PCR Analysis
Two µg of genomic DNA (gDNA) from PfWT, SR1PoFUT2
(single recombinant parasites before 5FCyt selection), and
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FIGURE 1 | PoFUT2 transfection constructs and integration events in human and rodent malaria parasites. (A) Scheme of the transfection plasmid (pCC1-PfPoFUT2)
used to target and disrupt PfPoFUT2 in P.falciparum NF54 parasites (PfWT) and the expected double crossover recombination event (Pf1PoFUT2). Black boxes
represent upstream and downstream DNA sequence flanking the PfPoFUT2 gene locus. Position of NdeI (N) sites, position of F1 probe (thick black line) and predicted
length of the restriction fragments (thick black lines) are shown. (B) Southern blot of NdeI digested genomic DNA from PfWT, SR1PoFUT2, and Pf1PoFUT2 parasite
clones hybridized with the F1 probe. SR refers to single recombinant parasites before negative selection with 5-FCyt. A 7.8Kb band (size of the pCC1-PfPoFUT2
plasmid) can be also observed in SR1PoFUT2 lane. (C) Scheme of the PlasmoGem transfection plasmid (PbGEM-283938) used to disrupt PbPoFUT2 in PbWT
parasites and the expected double crossover recombination events (Pb1PoFUT2). Black boxes represent upstream and downstream DNA sequence flanking the
PbPoFUT2 gene locus. Position of NotI, predicted length of PCR fragments (black lines), and position of primers pb1, pb3, pb4, and pb5 are shown. TelN refers to
telomerase, RepA to helicase, cB to arabinose-inducible origin, and KanR to the kanamycin resistance cassette. attB1 and attB2 are the recombination sequences for
the Gateway technology. (D) Genotype analysis of P. berghei transfectants. PCR using genomic DNA from PbWT, pyrimethamine-resistant population (PbPYR) and
Pb1PoFUT2 clones as template were done using primers pb3 and pb4, and pb5 and pb1for wild type locus and integration (PbPoFUT2 disruption), respectively.
Pf1PoFUT2 (P. falciparum PoFUT2 null mutant; four different
clones) were digested with NdeI and probed with 32P (Perkin
Elmer)-labeled F1 (Figure 1B).
Mice
BALB/c and C57BL/6 mice (6–8 weeks of age) were purchased
from Charles River and housed in the rodent facility of Instituto
de Medicina Molecular (Lisbon, Portugal).
Plasmodium berghei Transfection, Cloning,
and PCR Genotyping
Transfection experiments were performed using Plasmodium
berghei ANKA strain 2.34 parasites (Janse et al., 2006).
The PoFUT2 knockout vector PbGEM-283938 was obtained
from the PlasmoGEM resource (Pfander et al., 2011) (http://
plasmogem.sanger.ac.uk). The final knockout construct was
digested with NotI to release the fragment for transfection
(Figure 1C). The pyrimethamine-resistant parasite population
(PbPYR) containing the correct genomic integration substituting
PoFUT2 gene (Pb1PoFUT2) was cloned by injecting one
parasite per mouse (BALB/c male mice, 6–8 weeks of age)
to obtain Pb1PoFUT2. hu-dhfr cassette integration conveying
resistance to pyrimethamine was tested using primers pb1 (CA
TACTAGCCATTTTATGTG), pb3 (AGCACCACGGGGGAAG
GACT), pb4 (ATGCAAAAACGTCTTCCCTT), and pb5 (TCGA
GCAACGATAAAATGCCT) (Figure 1D).
P. falciparum Gametocyte Cultures and
Mosquito Infection
PfWT and Pf1PoFUT2were diluted to 0.5%mixed stage asexual
parasites and 4% hematocrit with complete culture media and
cultured at 37◦C using the candle jar method (Trager and Jensen,
1976). The media was exchanged daily from day 1 to day 17 to
allow for gametocyte maturation from stage I through stage V.
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Standard membrane feeding assays (SMFA) were performed on
day 15–18 post-culture initiation. Approximately 60 female An.
stephensi (SDA-500) or An. gambiae (KEELE) mosquitoes were
distributed into pint-sized cups and starved of sugar and water
for ≈ 12 h prior to feeding. PfWT and Pf1PoFUT2 gametocyte
cultures were pelleted and diluted to 0.03 or 0.3% gametocytemia
with human blood at 50% hematocrit. Blood was washed
with RPMI media and brought to 50% hematocrit with heat-
inactivated AB serum. Gametocytemic blood was kept at 37◦C
until feeding. Approximately 250–300 µL of gametocytemic
blood was dispensed into a water-jacketed membrane feeder at
37◦C, and mosquitoes were allowed to feed for a minimum of
45min. After blood feeding, non-blood fed mosquitoes were
removed. Blood fed mosquitoes were kept at 26◦C and 70%
humidity with a 12-h light:dark cycle. Mosquitoes were provided
a 10% sucrose solution for energy.
P. berghei Mosquito Infections
An. stephensi mosquitoes were bred at the insectary of the
Instituto de Medicina Molecular. For mosquito infection, female
BALB/c mice were intraperitoneally injected with P. berghei
wild type (PbWT) and Pb1PoFUT2 mutant lines. Three to 5
days post-infection, the number of exflagellation events was
determined using a Zeiss Axioskop 2 light microscope and a
counting grid. If > 1 exflagellation event per field of view was
observed,mice were anesthetizedwith amixture of 10% ketamine
and 2% xylazin in phosphate buffered saline (PBS) (100 µL per
20 g mouse body weight i.p.) and fed toAn. stephensimosquitoes.
Unfed mosquitoes were removed, and fed mosquitoes were
maintained at 19–22◦C in 50–80% relative humidity. Mosquitoes
were used 10–23 days post infection for further experiments.
Oocyst Counting and Imaging
For P. falciparum oocyst counting, mosquito midguts were
dissected 8 to 10 days post-feeding; midguts were stained with
0.2% mercurochrome in water for 9min. Midguts were placed
on a slide with a drop of PBS, overlaid with a coverslip, and
examined for oocysts using brightfield microscopy at 200×
total magnification. Each midgut was imaged with ProGres
CapturePro software to measure oocyst diameter, ensuring
oocyst in all planes were visible. Six biological replicates with
two technical replicates each were analyzed. P. berghei infected
midguts were collected and stained with 0.5% mercurochrome
10 days post-feeding. Oocysts were counted to determine the
intensity of infection (number of oocysts per midgut). Twelve
experiments were carried out, and generalized mixed effect
models (GLMM) were used for or statistical analysis.
Sporozoite Purification and Counting
On day 14 post-feeding, 30 mosquitoes infected with each P.
falciparum line (PfWT and Pf1PoFUT2) were dissected to
obtain salivary glands. Each pair of salivary glands was kept in
100 µL PBS in a 1.5mL tube. The tubes were spun at 1,200 ×
g for 3min at room temperature (RT). The salivary gland pellet
was gently crushed and vortexed for 3 s to resuspend the salivary
gland contents. The tubes were spun again and sporozoites
were counted blindly on a Zeiss Axioskop 2 microscope using
a hemocytometer and averaging counts from 2 fields. Unpaired
t-test was run using GraphPad (version 5.00). Three biological
replicates with two technical replicates each were performed.
P. berghei sporozoites (PbWT and Pb1PoFUT2) were collected
21–24 days post-feeding from infected An. stephensi females
bred at Instituto de Medicina Molecular. Salivary glands were
dissected and kept in non-supplemented RPMI media at 4◦C.
Salivary glands were then smashed in a microcentrifuge tube.
To eliminate mosquito debris and isolate sporozoites, samples
were filtered using a 70µm strainer. Sporozoites were counted
in a Neubauer chamber using an Olympus CKX41 inverted
microscope. Six experiments were performed using GLMM for
statistical analysis.
P. berghei Gliding Motility Assays
For gliding motility analysis, 20,000 P. berghei sporozoites
isolated from infected mosquito salivary glands were deposited
on glass slides coated with anti-CSP monoclonal antibody
(3D11mouse mAb, 10µg/mL final concentration) and incubated
at 37◦C for 1 h. Sporozoites were subsequently fixed in 4%
paraformaldehyde for 10min and blocked with 1% bovine serum
albumin (BSA) in PBS for 1 h at RT. Parasites were stained
with 3D11 antibody (10µg/mL) for 1 h at RT, followed by
three PBS washes. Sporozoites were further incubated (1:250)
with goat anti-mouse AlexaFluor 488 (Jackson ImmunoResearch
Laboratories). Three additional PBS washes were carried
out. Sporozoites associated with CSP trails were visualized
by fluorescence microscopy using a Zeiss Axiovert 200M
microscope. Quantification was performed by counting the
number of sporozoites performing < 3 circles, ≥ 3 and ≤ 10
circles, and> 10 circles.
Human Hepatoma Cell Culture and in vitro
Infection With P. berghei Parasites
Human hepatoma Huh7 cells were cultured in RPMI 1640 media
supplemented with 10% v/v fetal bovine serum, 0.1mM non-
essential amino acids, 50µg/mL penicillin/streptomycin, 2mM
glutamine, and 1mM HEPES (final concentrations) at pH 7 and
maintained at 37◦C with 5% CO2.
For in vitro hepatic infections, cells were seeded on glass
coverslips the day before infection. Sporozoite addition was
followed by 5min centrifugation at 1,800 × g. 48 h post-
infection, cells were fixed for 20min at RT and incubated with
permeabilization/blocking solution (0.1% v/v Triton X-100, 1%
w/v BSA in PBS) for 30min at RT. Parasites were stained with
an anti-UIS4 antibody (dilution 1:1,000, SICGEN # AB0042-200)
for 1 h at RT, washed three times, and further incubated with
anti-mouse AlexaFluor 488 secondary antibody (1:400 dilution)
in the presence of Hoechst 33258 (1:1,000 dilution, Thermo
Fisher Scientific) for nuclear staining. Coverslips were mounted
on microscope slides with Fluoromount (SouthernBiotech).
Widefield images for size determination were acquired with a
Zeiss Axiovert 200M microscope. Images were processed with
ImageJ software (version 1.47).
Sporozoite traversing activity was examined using a standard
cell-wounding and membrane repair assay. Huh7 cells (1.0× 104
per well) were seeded in 96-well plates the day before infection.
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Sporozoites were added to cells for 2 h in the presence of 0.5
mg/mL FITC-labeled dextran (Thermo Fisher Scientific). Cells
were collected for flow cytometry analysis 48 h post-infection and
analyzed on a Becton Dickinson LSR Fortessa flow cytometer
with the DIVA software (version 6.2). Analysis was carried out
using the FlowJo software (version 6.4.7, FlowJo).
P. berghei Sporozoite Infectivity to Mice
For transmission experiments, naïve C57BL/6 mice were exposed
to 10mosquitoes infected with PbWTor Pb1PoFUT2 for 30min;
5 mice were used per parasite clone. Parasitemias were followed
daily by counting Giemsa stained smears from a drop of tail
blood. Animals were monitored daily for clinical signs of cerebral
malaria (head deviation, convulsions, ataxia, and paraplegia).
Mice were euthanized when required, according to the approved
protocol, to avoid further stress and pain.
Statistical Analyses
GLMM was applied as described previously (Churcher et al.,
2012) to test for differences between the prevalence of oocysts
(assuming a binomial distribution error structure) and the
average number of oocysts per mosquito (assuming a negative
binomial distribution) (Bolker et al., 2012; Churcher et al., 2012).
GraphPad Prism version 6 was used for standard statistical
analyses as indicated in the respective sections above.
RESULTS
Creation of Plasmodium PoFUT2 Null
Mutants (Pf1PoFUT2 and Pb1PoFUT2)
To study the function of PoFUT2 in Plasmodium parasites,
we knocked out this gene in the human malaria parasite P.
falciparum. P. falciparum PoFUT2 (PfPoFUT2) was disrupted
by double crossover recombination using a targeting construct
(pCC1-PfPoFUT2; Maier et al., 2006) that replaced the gene with
a hu-dhfr selection cassette in the P. falciparum NF54 line, the
same parasite line used by Lopaticki et al. (Lopaticki et al., 2017).
To add robustness to our experimental data, a similar approach
was used to ablate P. berghei PoFUT2 (PbPoFUT2) in ANKA
strain 2.34 parasites, using the available PlasmoGEM resource
PbGEM-283938 plasmid (Pfander et al., 2011). After cloning hu-
dhfr resistant parasites by limiting dilution, PCR or Southern
blot analyses confirmed PoFUT2 disruption in two clones from
both Plasmodium species (Figure 1). As reported (Lopaticki et al.,
2017), the ability to produce PoFUT2 null-mutant parasites
demonstrates that the gene is not essential for asexual blood stage
growth in culture or in a rodent model of infection.
Oocyst Infection of Mosquito Midguts Is
Similar in Pf1PoFUT2 and PfWT
Considering the importance of TSR domain-containing proteins
such as CTRP, CSP, and TRAP in the mosquito stages of
parasite development, we examined the function of PoFUT2
throughout the complete life cycle of Plasmodium. Notably,
CTRP is an ookinete surface protein containing 7 TSR domains
and 5 conserved O-fucosylation motifs that plays a critical
role in Plasmodium invasion of the Anopheles midgut (Dessens
et al., 1999). To understand the importance of PoFUT2 for
oocyst infection, we infected An. gambiae mosquitoes with
PfWT and Pf1PoFUT2 gametocyte cultures. Recognizing the
inherent variation from experiment to experiment when using
SMFA for mosquito infections (Churcher et al., 2012), we
conducted 12 experiments to capture the entire variation in
oocyst development in the mosquito midgut.
We quantified the P. falciparum oocyst numbers on the
An. gambiae midgut wall following PfWT or Pf1PoFUT2
parasite infection (Figure 2A). GLMM was used to test for
differences between the average number of oocysts (assuming
a negative binomial distribution) and oocyst prevalence
(assuming a binomial distribution; Churcher et al., 2012).
An average difference between PfWT and Pf1PoFUT2
parasites was calculated by including replicate number as a
random effect, which accounts for differences in infectivity
between the replicates. There was no significant difference in P.
falciparum oocyst intensity (P value = 0.517) and prevalence
(P value= 0.963) (Figure 2B). Furthermore, the diameter and
mean size of P. falciparum oocysts were comparable for PfWT
and Pf1PoFUT2 parasites (Supplementary Figures 1A–D). Six
biological replicates (with two technical replicates each) were
performed with P. falciparum parasites.
PoFUT2 Is Not Required for An. gambiae
Salivary Gland Infection by Sporozoites
CSP is an important sporozoite surface protein with a single
O-fucosylation site in the TSR domain. We quantified the
number of sporozoites per salivary gland pair at day 14 post-
blood feeding for P. falciparum. Three biological replicates (with
two technical replicates each for a total of 6 experiments) were
performed with P. falciparum (Supplementary Figure S2A).
Using a GLMM approach, we observed that Anopheles
mosquitoes carrying null-mutant or wild type parasites showed
comparable numbers of salivary gland sporozoites (intensity
counts P value = 0.446, prevalence P value = 0.645). Hence,
PoFUT2 does not play a critical role for parasite maturation in
oocysts or salivary gland colonization.
PoFUT2 Is Not Essential in a Murine
Malaria Model
To examine the cross-species role of PoFUT2, additional
functional assays were carried out with P. berghei parasites
lacking PoFUT2 (Pb1PoFUT2). The murine malaria model
allows for the use of non-transgenic mice, which are infected
routinely by P. berghei sporozoites. We infected An. stephensi
mosquitoes with PbWT and Pb1PoFUT2 parasites and
examined oocyst intensity and prevalence, salivary gland
sporozoite characteristics, and in vivo infection of mice. In the P.
berghei-An. stephensi model, there was no significant difference
in P. berghei oocyst intensity (P value = 0.656) and prevalence
(P value= 0.962); which corroborated our P. falciparum results
in An. gambiae
Sporozoite motility assays (Figure 2C) and in vitro hepatic
infection experiments with Pb1PoFUT2 mutant parasites
(Supplementary Figures 2B,C) produced comparable results
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FIGURE 2 | Wild type and PoFUT2 mutant Plasmodium parasites demonstrate comparable infectiousness to mosquitoes but exhibit species-specific difference in
infection phenotypes for mosquito-mammal transmission. (A) An. gambiae female mosquitoes (N = 30 per group) were fed with PfWT (open) and Pf1PoFUT2
(closed), and oocyst number per midgut was counted 8 days post-feed for two gametocyte concentrations: 0.03% (blue) and 0.3% (red). Two representative replicate
experiments at each gametocyte concentration (R1, R2) are shown. Horizontal bars indicate the mean oocyst number per midgut. (B) Generalized Linear Mix Model
statistical analysis of the mean oocyst intensity and infection prevalence from SMFAs performed with PfWT or Pf1PoFUT2 in either 0.03% gametocytemia (blue) or
0.3% gametocytemia (red). Black dotted line indicates no difference between the two groups of mosquitoes; colored vertical, and horizontal lines denote 95%
confidence intervals for the point estimates. (C) Motility assays were performed for PbWT and Pb1PoFUT parasites to monitor CSP trails (left panels). The number of
trails for each sporozoite was classified as < 3 circles (dark gray), 3–10 circles (light gray), or > 10 circles (white; right panel). (D) C57BL/6 mice were infected by
mosquito direct feeding with PbWT (gray line) or Pb1PoFUT2 (red line) and monitored for patency (blood stage infection) and subsequent survival.
betweenWT and null-mutant parasites. Finally, two independent
experiments performed with P. berghei showed that Pb1PoFUT2
sporozoites were able to infect C57BL/6 mice in mosquito
“bite-back” direct feeding experiments (Figure 2D). For PbWT
(gray lines, Figure 2D), 4/5 mice succumbed to cerebral
malaria (2 at day 9 and 2 at day 10) and the fifth mouse
that remained alive with high parasitemia was sacrificed on
day 10. For Pb1PoFUT2 (red lines, Figure 2D), 4/5 mice
succumbed to cerebral malaria (2 at day 7, 1 at day 9,
and 1 at day 10) and the fifth mouse that remained alive
with high parasitemia was sacrificed on day 10. Comparable
sporozoite numbers developed in mosquitoes for both PbWT
and Pb1PoFUT2 (Table 1), akin to what was observed for P.
falciparum (Supplementary Figure 2A). The apparent reduction
in sporozoites/salivary gland pair in Experiment A is not
reproducible (as shown in Experiment B), underscoring the
variation in the system. These results demonstrated that
Pb1PoFUT2 mutants are fully infectious and able to progress
TABLE 1 | Plasmodium berghei WT and Pb1PoFUT2 “bite back” infections in
mice.
Expt PbWT (N) % Infected
mice (n/N)
Pb1PoFUT2
(N)
% Infected
mice (n/N)
A 114,000/mosquito (13) 100% (5/5) 65,019/mosquito (13) 100% (5/5)
B 133,750/mosquito (10) 100% (5/5) 148,255/mosquito (10) 100% (5/5)
through skin passage, hepatocyte infection, and intrahepatic or
liver stage development.
DISCUSSION
O-fucosylation, the process of adding a fucose residue to the
-OH side chain of serines or threonines in TSR cysteine-
rich domains (Leonhard-Melief and Haltiwanger, 2010), is
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 6 July 2019 | Volume 9 | Article 238
Sanz et al. PoFUT2 in Murine Malaria Transmission
mediated by PoFUT2 O-fucosyltransferase (Valero-González
et al., 2016). The O-fucosylation of P. falciparum CSP and TRAP
sporozoite proteins has been recently demonstrated (Swearingen
et al., 2016). Considering the relevance of these and other
TSR domain-containing proteins for Plasmodium invasion and
motility (Morahan et al., 2009), we created a PoFUT2 null-
mutant in human and rodent parasites to completely assess
the effect of PoFUT2 disruption throughout the parasite life
cycle. We observed that PoFUT2 was not required for either
P. falciparum or P. berghei infection of Anopheles mosquitoes
by counting the number of oocysts per midgut. These data are
in clear contrast to the reported observation by Lopaticki et al.
(2017), which pooled data from replicate assays. Pooling data
without statistical support may generate misleading results, as
there can be large variability in average oocyst counts between
replicates (as seen in Figure 2B) with single studies biasing
overall estimates. However, testing differences using robust
and adequate GLMMs is more appropriate to analyze SMFA
assays (Churcher et al., 2012), which have a high variability
risk due to the use of different sources of blood, cages, or
feeders and the generation of highly dispersed data. GLMM,
a multi-level analysis enabling the estimation of a fixed effect
(number of oocysts) while allowing the level of infection in
different assays to vary at random, is the statistical model of
choice for assessing parasite infectiousness to mosquito vectors
(Churcher et al., 2015; Kapulu et al., 2015).
Remarkably, our primary parasite-mosquito model pits an
African parasite (NF54) with an African mosquito vector
(An. gambiae KEELE), which represents the closest natural
combination in laboratory studies. An. stephensi (SDA-500) has
also been the customary laboratory vector for P. berghei studies.
Although other groups have used An. stephensi-P. falciparum
(NF54) combinations, we have found that the overall mean
oocyst intensity tends to be lower than what is observed for An.
gambiae-P. falciparum. We tested two gametocyte densities of
0.03 and 0.3% to determine whether any potential phenotypes
would be observed at lower parasite densities during mosquito
infection. In both cases, no reductions in oocyst development
were observed. Therefore, in our hands PoFUT2 disruption did
not affect oocyst development in the most relevant parasite-
mosquito species combinations in a laboratory setting for both
human and murine malaria models.
CSP and TRAP are important sporozoite TSR domain-
containing proteins which are O-fucosylated by PoFUT2
(Swearingen et al., 2016). However, Plasmodium PoFUT2 null-
mutants and wild type parasites showed comparable numbers of
sporozoites in mosquito salivary glands. Furthermore, sporozoite
motility, and infectivity was similar in PbWT and Pb1PoFUT2
parasites, in agreement with mouse infectivity data. Interestingly,
TRAP secretion appears to have been partly affected in the
work published by Lopaticki et al. (2017). This is not surprising,
as it is known that the intensity of attenuated PoFUT2-
ablation phenotypes are protein-specific (Vasudevan et al., 2015).
However, the ookinete and sporozoite infectivity in mosquitoes
and vertebrates, respectively, remains unchanged; indicating that
functional redundancy or the presence of multiple parasite
“invasins” ensures the success of the malaria parasite during
transmission. As Lopaticki et al. (2017), mention in their study,
the absence of many genes necessary for classical glycosylation
in Plasmodium genomes (von Itzstein et al., 2008; Cova et al.,
2015), together with some contradictory results (Kimura et al.,
1996; Gowda et al., 1997), fueled the debate about the existence of
protein glycosylation in the malaria parasite, with the exception
of glycosylphosphatidylinositol anchors (Naik et al., 2000).
Recently, studies are casting new light on this issue (Bushkin
et al., 2010; Sanz et al., 2013, 2016; Swearingen et al., 2016;
López-Gutiérrez et al., 2017). Additionally, recent work exploring
the function of PoFUT2 in Toxoplasma gondii, a Plasmodium
related parasite, also revealed discrepancies in the effect of
PoFUT2 null mutants on microneme protein 2 secretion and
host cell attachment and invasion (Bandini et al., 2019; Gas-
Pascual et al., 2019; Khurana et al., 2019). Our results suggest
that within Plasmodia, nuanced differences with respect to
developmental biology and host preference can also result in the
observation of diverse phenotypes, which in this case is specific
toO-fucosylation of sporozoite TSR domain-containing proteins.
Taking into account previous and current controversies about
the glycobiology of Plasmodium and our experimental results
reported here, we note that caution must be exercised before
considering protein O-fucosylation as a strict requirement for
the efficient infection of mosquito and vertebrate hosts for all
Plasmodium species.
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Supplementary Figure 1 | Oocyst development as a proxy-measure for
successful ookinete invasion of the mosquito midgut epithelium is not impacted in
Pf1PoFUT2 parasites. (A,B) Brightfield images of mercurochrome-stained PfWT
or Pf1PoFUT2 oocysts. (C,D) The range of Plasmodium falciparum oocyst
diameters within individually mosquitoes (µm) (C) and the mean diameter of
oocysts for all infected mosquitoes (µm) (D) of the PfWT (white) and Pf1PoFUT2
(gray) oocyst is represented. Unpaired t-test P value = 0.6897. The horizontal bar
indicates the mean oocyst diameter.
Supplementary Figure 2 | Sporozoite development, motility, and infection of
hepatocytes by null-mutant parasites is unaffected. (A) P. falciparum sporozoites
(PfWT and Pf1PoFUT2) were counted on day 14 post-blood feeding. Two
representative experiments of six total are shown. (B) in vitro hepatocyte infection
of Huh7 cells normalized to PbWT infection as 100%. Mann-Whitney U test P
value = 0.1716. (C) Exoerythrocytic form (EEF) size in Huh7 hepatocyte cell
infection model with PbWT and Pb1PoFUT2 sporozoites. Unpaired t-test
P value = 0.3931.
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